Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$5.04K Hold
104
﹤0.01% 1219
2025
Q3
$4.91K Hold
104
﹤0.01% 1134
2025
Q2
$5.1K Buy
+104
New +$5.31K ﹤0.01% 1052
2025
Q1
Sell
-1,681
Closed -$81.1K 1577
2024
Q4
$81.1K Buy
1,681
+253
+18% +$12.9K 0.01% 465
2024
Q3
$82.3K Sell
1,428
-103
-7% -$5.56K 0.01% 421
2024
Q2
$75.9K Buy
1,531
+20
+1% +$965 0.01% 689
2024
Q1
$73K Buy
+1,511
New +$73.8K 0.14% 101
2023
Q4
Sell
-1,270
Closed -$68.1K 1320
2023
Q3
$68.1K Sell
1,270
-246
-16% -$13.1K 0.02% 472
2023
Q2
$81.3K Buy
+1,516
New +$81.6K 0.01% 569

Other funds holding SNY

ORG Partners's SNY Position: Q4 2025 in Review

ORG Partners held its Sanofi (SNY) position steady in Q4 2025 at 104 shares worth $5.04K. The position accounts for ﹤0.01% of the portfolio, ranked #1219.

ORG Partners first reported a position in SNY in Q2 2023 and has held it in 9 quarters since. The position peaked at $82.3K in Q3 2024. 757 funds tracked by Wall St. Rank hold SNY as of Q4 2025.

  • ORG Partners held 104 shares of Sanofi worth $5.04K as of Q4 2025.
  • ORG Partners left its Sanofi share count unchanged in Q4 2025.
  • Sanofi made up ﹤0.01% of ORG Partners's portfolio in Q4 2025, its #1219 holding.
  • ORG Partners first reported a position in Sanofi in Q2 2023 and has held it in 9 quarters since.
  • ORG Partners's Sanofi position peaked at $82.3K in Q3 2024.
  • 757 funds tracked by Wall St. Rank held Sanofi as of Q4 2025.

Based on ORG Partners's 13F filing for Q4 2025, filed 14 Jan 2026.